For decades, LDL cholesterol has been the primary focus in cardiovascular health..and A1C in metabolic health. The research now clearly supports new, more representative indicators, like TyG, FLI, AIP, RC…following is selected research that supports a new paradigm in cardiometabolic risk assessment.
93.2% Not In Optimal Cardiometabolic Health 2018 Survey
US Survey of 55,000 adults indicating just 6.8% were in optimal cardiometabolic health.
Triglyceride-Glucose WHtR Best for Atherosclerosis
15 year study following 95,000+ subjects comparing various TyG index variants.
Remnant Cholesterol Reveals Residual Risk with Statins
In patients that are “well controlled” on statin medications, with LDL Cholesterol at or below 70 mg/dl, Remnant Cholesterol can reveal residual risk of heart disease.
Remnant Cholesterol Superior to ApoB for Atheroma Growth
In patients with diagnosed coronary artery disease, on treatment with statins, Remnant Cholesterol proved superior to ApoB and LDL in predicting risk of progression of atheroma.
TyG-Waist/Height Ratio Predicts CV, T2DM, Death in MetS
Triglyceride-Glucose Index-Waist-Height Ratio Predicts Risk of Cardiovascular Disease, Diabetes and Mortality in Metabolic Syndrome.
Atherogenic Index Predictive of Stroke over 0.12
In patients followed for over 8 years in their late 50’s, an Atherogenic Index over 0.12 increased first stroke risk by 35-84%.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.